Next-generation sequencing platforms are opening up new opportunities in precision medicine by dramatically reducing the cost and time to access large volumes of genomic data.
This webcast will highlight innovative technologies being developed by companies in the field, and how they are laying the groundwork for novel therapeutics and diagnostics in areas such as oncology and rare diseases. The topics will include advanced bioinformatics and next-generation sequencing for pathogen detection, nanosensor technology for genome sequencing and healthcare diagnostics, molecular indexing technology for digital detection of single cells and cloud-based accelerated genomics analysis.
The webcast will conclude with a live roundtable discussion and a Q&A section to allow you to hear the views of the speakers and to put your own questions to them.
Crystal R Icenhour, Aperiomics, Inc.
In 2014, Crystal R Icenhour, PhD was recruited to serve as founding CEO of Aperiomics, Inc. Aperiomics is a service laboratory specializing in harnessing the power of next-generation sequencing to improve world health. She is also an adjunct assistant professor at Duke University Medical Center’s Division of Infectious Diseases in their Department of Medicine. Dr. Icenhour currently serves as Chairman of Virginia BIO and was chosen to participate in the SpringBoard Enterprises 2016 class of women-led companies. She is a member of, Sigma Xi, Medical Mycology Society of the Americas, National Postdoctoral Association, and the American Society for Microbiology.